Apyx Medical
APYX
37 hedge funds and large institutions have $19.3M invested in Apyx Medical in 2017 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 11 closing their positions.
18% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 11
5% less funds holding
Funds holding: 39 → 37 (-2)
40% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 10
40% less capital invested
Capital invested by funds: $32.4M → $19.3M (-$13.1M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $41K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$315K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$221K |
| 3 |
CPA
Cowen Prime Advisors
New York
|
+$104K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$103K |
| 5 |
SIC
Salem Investment Counselors
Winston Salem,
North Carolina
|
+$98.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
-$1.88M |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$1.87M |
| 3 |
EI
EAM Investors
Solana Beach,
California
|
-$1.07M |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$718K |
| 5 |
MHP
Manatuck Hill Partners
Westport,
Connecticut
|
-$449K |
APYX Hedge Fund Activity: Q1 2017 in Review
37 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in Apyx Medical (APYX) for Q1 2017, worth a combined $19.3M — down 40% from $32.4M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new APYX positions and 11 closed out — a net gain of 2 holders — while 6 added to existing stakes and 10 trimmed.
The largest buyer was BlackRock, opening a new position worth an estimated $315K. The largest seller was Cortina Asset Management, cutting an estimated $1.88M.
- 37 institutional investors held Apyx Medical (APYX) as of Q1 2017, down from 39 in Q4 2016.
- Funds reported $19.3M of Apyx Medical stock for Q1 2017, down 40% quarter-over-quarter.
- 13 funds opened new Apyx Medical positions in Q1 2017 and 11 closed out, a net change of +2 holders.
- The largest Apyx Medical buyer in Q1 2017 was BlackRock, an estimated $315K added.
- The largest Apyx Medical seller in Q1 2017 was Cortina Asset Management, an estimated $1.88M sold.
Based on aggregated 13F filings for Q1 2017.